Board fixes Record date of August 11, 2026 for the Final Dividend
GLAND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 17.4 pts more than Nifty Smallcap 250 and 16.6 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Gland Pharma's Board has recommended a final dividend of Rs. 20 per equity share (face value Rs. 1 each) for FY 2025-26, equivalent to 2000% return per share. The record date for determining eligible shareholders is August 11, 2026, and the dividend will be paid within 30 days of the 48th AGM scheduled for August 25, 2026. The Board also approved audited consolidated financial results for Q4 and FY ended March 31, 2026, with standalone and consolidated net profit of Rs. 4,675.89 million for the full year. Statutory auditors Deloitte Haskins & Sells issued an unmodified opinion on the annual financial statements.
The dividend recommendation of Rs. 20 per share signals strong financial health and consistent shareholder returns. Investors holding shares before August 11, 2026 record date will be eligible to receive this dividend, subject to shareholder approval at the AGM.